OSCR

Integrative Bioinformatic Analysis Identifies Key Genes Driving Breast Cancer Brain Metastasis.

Overview

  1. Department of Radiology, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan; (W.-Y.T.); (Y.-H.L.)
  2. Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, New Taipei City 23561, Taiwan
Journal: Diagnostics (Basel, Switzerland), volume 16, issue 8, article 1149
Dates: received 18 March 2026; accepted 7 April 2026; published online 13 April 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3390/diagnostics16081149 · PMID 42072775 · PMCID PMC13115110 · OpenAlex W7153972491
Open access: gold, a free copy (OpenAlex)
Categories: other condition (population)
Methods: Statistics, Connectivity
Keywords: breast cancer, brain metastasis, bioinformatics, biomarker, cell cycle, metabolism
Topic: 14-3-3 protein interactions (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Citations: not cited yet (Europe PMC); 35 references in the paper

Abstract

Background/Objectives: Brain metastasis (BM) represents a significant clinical challenge in advanced breast cancer, yet the molecular mechanisms driving breast cancer brain metastasis (BCBM) remain incompletely characterized. This study aims to identify key molecular pathways and hub genes specifically associated with BCBM through comprehensive bioinformatic analyses. Methods: Gene Set Enrichment Analysis (GSEA), differential gene expression analysis, and weighted gene co-expression network analysis (WGCNA) were performed using two independent GEO datasets (GSE191230 and GSE43837). Protein–protein interaction (PPI) networks were constructed to visualize functional interconnections among dysregulated genes. Survival analyses were conducted using the Kaplan–Meier Plotter database to evaluate the prognostic significance of identified hub genes. Results: GSEA revealed significant upregulation of metabolic pathways (mTORC1 signaling, glycolysis, oxidative phosphorylation) and downregulation of immune-related pathways in BCBM compared to primary tumors. Integrative analysis identified 34 consistently dysregulated genes across datasets, from which 12 hub genes were validated. Among these, RRM2, CDCA8, CCNB1, LMNB2, FANCI, NCAPH, YWHAZ, and ESPL1 demonstrated brain-specific over-expression compared to other metastatic sites. Functional enrichment analysis highlighted cell cycle dysregulation as a critical mechanism in BCBM, and all hub genes showed significant association with poor prognosis in breast cancer patients. Conclusions: This study identifies a unique molecular profile of BCBM characterized by cell cycle dysregulation, metabolic reprogramming, and immune microenvironment alterations. The brain-specific expression patterns of these hub genes represent potential biomarkers for BCBM risk assessment and novel therapeutic targets, providing a basis for precision medicine development.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Other data links

Data Availability Statement

The original contributions presented in this study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 29 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 3 authors, 6 keywords, 35 references.

Cite

This paper

Ting, W.-Y., Lu, Y.-H., & Lin, C.-M. (2026). Integrative Bioinformatic Analysis Identifies Key Genes Driving Breast Cancer Brain Metastasis. Diagnostics (Basel, Switzerland), 16(8), 1149. https://doi.org/10.3390/diagnostics16081149

BibTeX

@article{ting2026integrative,
author = {Ting, Wei-Yi and Lu, Yueh-Hsun and Lin, Che-Ming},
title = {{Integrative Bioinformatic Analysis Identifies Key Genes Driving Breast Cancer Brain Metastasis}},
journal = {Diagnostics (Basel, Switzerland)},
year = {2026},
month = apr,
volume = {16},
number = {8},
pages = {1149},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {2075-4418},
doi = {10.3390/diagnostics16081149},
url = {https://doi.org/10.3390/diagnostics16081149},
pmid = {42072775},
pmcid = {PMC13115110}
}

RIS

TY - JOUR
AU - Ting, Wei-Yi
AU - Lu, Yueh-Hsun
AU - Lin, Che-Ming
TI - Integrative Bioinformatic Analysis Identifies Key Genes Driving Breast Cancer Brain Metastasis
T2 - Diagnostics (Basel, Switzerland)
J2 - Diagnostics (Basel)
PY - 2026
DA - 2026/04/13
VL - 16
IS - 8
SP - 1149
SN - 2075-4418
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/diagnostics16081149
UR - https://doi.org/10.3390/diagnostics16081149
LA - en
ER -

CSL-JSON

{
"id": "10.3390/diagnostics16081149",
"type": "article-journal",
"title": "Integrative Bioinformatic Analysis Identifies Key Genes Driving Breast Cancer Brain Metastasis",
"container-title": "Diagnostics (Basel, Switzerland)",
"author": [
{
"family": "Ting",
"given": "Wei-Yi"
},
{
"family": "Lu",
"given": "Yueh-Hsun"
},
{
"family": "Lin",
"given": "Che-Ming"
}
],
"container-title-short": "Diagnostics (Basel)",
"volume": "16",
"issue": "8",
"page": "1149",
"DOI": "10.3390/diagnostics16081149",
"PMID": "42072775",
"PMCID": "PMC13115110",
"ISSN": "2075-4418",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://doi.org/10.3390/diagnostics16081149",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
13
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3389/fimmu.2023.1305644
Unlocking molecular mechanisms and identifying druggable targets in matched-paired brain metastasis of breast and lung cancers.
Journal: Frontiers in immunology
In common: other condition, 4 references
[2] doi:10.3724/abbs.2025082
The lncRNA DANCR promotes breast cancer brain metastasis by acting as a ceRNA for miR-758-3p to regulate PTGS2 expression.
Journal: Acta biochimica et biophysica Sinica
In common: other condition, 4 references
[3] doi:10.3389/fonc.2022.965136
DIRAS3, GPR171 and RAC2 were identified as the key molecular patterns associated with brain metastasis of breast cancer.
Journal: Frontiers in oncology
In common: other condition, 3 references
[4] doi:10.1038/s41467-025-60730-4
Ghrelin-induced neuronal NPY promotes brain metastasis in lung cancer patients with low BMI.
Journal: Nature communications
In common: other condition, 3 references
[5] doi:10.1126/sciadv.adt3075
FAM50A drives breast cancer brain metastasis through interaction with C9ORF78 to enhance ʟ-asparagine production.
Journal: Science advances
In common: other condition, 3 references
[6] doi:10.1073/pnas.2205247120
An HLA-G/SPAG9/STAT3 axis promotes brain metastases.
Journal: Proceedings of the National Academy of Sciences of the United States of America
In common: other condition, 3 references
[7] doi:10.15252/emmm.202114552
A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.
Journal: EMBO molecular medicine
In common: other condition, 3 references
[8] doi:10.5306/wjco.v14.i11.445
Analysis of clinicopathological features and prognostic factors of breast cancer brain metastasis.
Journal: World journal of clinical oncology
In common: other condition, 3 references
[9] doi:10.1002/cnr2.70360
Bioinformatic Characterization of Genes That Are Correlated to the Progression of Breast Cancer to Breast Cancer Brain Metastasis.
Journal: Cancer reports (Hoboken, N.J.)
In common: other condition, 2 references
[10] doi:10.3390/jcm15176501 [code]
Saliency-Curated Deep Learning for Predicting Receptor Status in Breast Cancer Brain Metastases.
Journal: Journal of clinical medicine
In common: other condition, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.